East Asia may have a better 1-year survival following an acute heart failure episode compared with Europe: results from an international observational cohort

Autoři	AKIYAMA E. VAN AELST L.N.L. ARRIGO M. LASSUS J. MIRO O. CELUTKIENE J. CHOI D.J. COHEN-SOLAL A.. ISHIHARA S. KAJIMOTO K. LARIBI S. MAGGIONI A.P. MOTIEJUNAITE J. MUELLER C. PAŘENICA Jiří PARK J.J. SATO N. ŠPINAR Jindřich ZHANG J. ZHANG Y.H. KIMURA K. TAMURA K. GAYAT E. MEBAZAA A.
Rok publikování	2018
Druh	Článek v odborném periodiku
Časopis / Zdroj	European Journal of heart Failure
Fakulta / Pracoviště MU	Lékařská fakulta
Citace
Doi	http://dx.doi.org/10.1002/ejhf.1152
Klíčová slova	acute heart failure
Popis	Acute heart failure (AHF) is a major health problem worldwide and trials to assess novel therapies are increasingly global, as a means to reduce costs, expedite timelines, provide broad applicability, and satisfy regulatory authorities.The significant geographic differences in patient characteristics, outcomes, and treatment effect may affect trial results and raise important questions about generalizability of the results to a broader population.